TTS Pharma is led by an experienced management team with pharmaceutical and public company expertise and a proven track record of innovative, and effective product development and supply chain management.
Chief Executive Officer
Mark licensed the first nicotine patch to Novartis (CIBA) in 1989 and has five other drug delivery patents. Mark worked at Penn Pharma in the 1990’s where Thalidomide was manufactured and re-introduced (by Celgene) into mainstream healthcare. He also successfully developed one of the first NHS-led Companion Diagnostics in UK and has overseen an international manufacturing and supply chain incorporating a GMP manufacturing site in China.
Mr. Wilson Blaney BSc (Hons)